Prosecution Insights
Last updated: October 02, 2026

Examiner: FUBARA, BLESSING M

Tech Center 3700 • Art Units: 1613 1614 1615 1618 1693 3774

This examiner grants 62% of resolved cases

Analysis

Examiner Blessing M Fubara works in Tech Center 3700 and Art Unit 1613. There are 1292 resolved cases with an allowance rate of 62.2 percent. This percentage provides a metric for the probability of a grant. The median days to allowance is 1196. This timeframe is a factor in managing patent applications for clients.

The interview lift is 34.3 percent. For the 1292 resolved cases, this lift shows the correlation between interviews and outcomes. The 1196 days to allowance serves as a benchmark for pendency. Practitioners can use the 62.2 percent allowance rate and the Art Unit 1613 data to inform strategy for their applications. These metrics from Tech Center 3700 assist in prosecution planning for the office.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

62.2%
Allow Rate
-7.8% vs TC avg
1,328
Total Applications
+34.3%
Interview Lift
1196
Avg Prosecution Days
Based on 1292 resolved cases, 2023–2026

Rejection Statute Breakdown

2.0%
§101 Eligibility
15.5%
§102 Novelty
36.3%
§103 Obviousness
22.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18248615 COMPOSITIONS AND METHODS PROMOTING GROWTH OF PERIPHERAL NERVOUS TISSUE Final Rejection MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
18317780 SURFACE-MODIFIED ANASTOMOSIS DEVICE Non-Final OA Washington University
18250810 Process for the three-dimensional shaping of a tissue or tissue component Non-Final OA BIOTRONIK AG
18283344 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS Non-Final OA The Board of Regents of the University of Texas System
18702531 NANOPARTICLE-BASED ABUSE-DETERRENT FORMULATIONS AND METHODS OF MAKING AND USING Non-Final OA Purdue Research Foundation
18722637 AQUEOUS LIQUID COSMETIC MATERIAL Non-Final OA MITSUBISHI PENCIL COMPANY, LIMITED
18577357 COMPOSITION COMPRISING A (METH)ACRYLATE COPOLYMER, AN ALKALI OR AMMONIUM SALT OF A SATURATED ALIPHATIC MONOCARBOXYLIC ACID AND SPECIFIC GLIDANTS Non-Final OA Evonik Operations GmbH
18977210 Ribociclib Tablet Final Rejection Novartis AG
18588259 Ribociclib Tablet Final Rejection Novartis AG
17623348 COMPOSITION COMPRISING A NATURAL DYE, A HYDRAZONO AND/OR AZO CATIONIC SYNTHETIC DIRECT DYE AND AN AROMATIC COMPOUND Final Rejection L'OREAL
18787155 Oral Care Compositions Non-Final OA Colgate-Palmolive Company
18703032 HAIR COSMETIC COMPOSITION Non-Final OA KAO CORPORATION
18293235 HAIR COSMETIC COMPOSITION Final Rejection KAO CORPORATION
18778380 Core-Shell Microcapsule with a Polyamine-Based Thermosetting Shell Non-Final OA GIVAUDAN SA
18722739 OIL-IN-WATER EMULSIFIED COSMETIC COMPOSITION Non-Final OA L V M H RECHERCHE

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month